CIK: 1724097 - Address: 12780 El Camino Real, San Diego, CA 92130
25 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
8/15/24 17:12
8/13/24
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS.d-2,120150.380-14-3132D
8/15/24 17:12
8/13/24
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOM.d1,03873.600148132D
7/18/24 16:45
7/16/24
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS.d-135150.040-1-332D
7/18/24 16:45
7/16/24
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOM.d6673.6001332D
5/16/24 16:40
5/14/24
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS.dm-4,138137.950-30-4932D
5/16/24 16:40
5/14/24
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOM.dm2,20873.60030999%32D
2/15/24 17:27
2/13/24
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS.d-180132.850-1-432D
2/8/24 19:12
2/6/24
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS.m-314138.730-2-730D
2/2/24 19:00
1/31/24
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS-181140.720-1-428D
8/23/23 19:58
8/21/23
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS-229107.390-2-727D
2/8/23 19:16
2/6/23
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS.m-2,933102.610-29-5325D
2/2/23 16:53
1/31/23
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS-141109.980-1-621D
2/9/22 18:51
2/7/22
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS.m-34580.530-4-1820D
12/3/21 17:02
12/1/21
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS-13682.590-2-916D
2/9/21 21:30
2/8/21
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS.d-340116.820-3-1615D
12/2/20 16:12
12/1/20
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS-15694.660-2-1311D
11/16/20 18:02
11/12/20
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS-20590.740-2-1810D
8/7/20 18:22
8/5/20
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS-268118.900-2-228D
5/11/20 20:17
5/7/20
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS.d-1,653110.210-15-726D
5/11/20 20:17
5/7/20
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOM.d1,10473.600156D
4/30/20 16:25
4/28/20
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS-178102.490-2-236D
4/28/20 20:32
4/24/20
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS-19299.520-2-208D
2/11/20 19:06
2/7/20
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS-210103.350-2-266D
12/4/19 18:06
12/2/19
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS-191116.330-2-304D
12/6/18 17:54
12/3/18
NBIXNeurocrine Biosciences IncCAHealthBioPrdBiological Products, (No DiagAbernethy MattCAOCFOS-10690.000-1-382D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact